Igor Ferraz da Silva1*
Leandro Ceotto Freitas-Lima2
Jones Bernardes Graceli2
Lívia Carla de Melo Rodrigues1
- 1Laboratory of Neurotoxicology and Psychopharmacology, Department of Physiological Sciences, Federal University of Espirito Santo, Vitória, Brazil
- 2Laboratory of Endocrinology and Cellular Toxicology, Department of Morphology, Federal University of Espirito Santo, Vitória, Brazil
The consequences of exposure to environmental contaminants have shown significant effects on brain function and behavior in different experimental models. The endocrine-disrupting chemicals (EDC) present various classes of pollutants with potential neurotoxic actions, such as organotins (OTs). OTs have received special attention due to their toxic effects on the central nervous system, leading to abnormal mammalian neuroendocrine axis function. OTs are organometallic pollutants with a tin atom bound to one or more carbon atoms. OT exposure may occur through the food chain and/or contaminated water, since they have multiple applications in industry and agriculture. In addition, OTs have been used with few legal restrictions in the last decades, despite being highly toxic. In addition to their action as EDC, OTs can also cross the blood–brain barrier and show relevant neurotoxic effects, as observed in several animal model studies specifically involving the development of neurodegenerative processes, neuroinflammation, and oxidative stress. Thus, the aim of this short review is to summarize the toxic effects of the most common OT compounds, such as trimethyltin, tributyltin, triethyltin, and triphenyltin, on the brain with a focus on neuronal damage as a result of oxidative stress and neuroinflammation. We also aim to present evidence for the disruption of behavioral functions, neurotransmitters, and neuroendocrine pathways caused by OTs.
Introduction
In recent neurotoxicology studies, there is a growing interest in chemical pollutants with endocrine disruptor properties (1). Endocrine-disrupting chemicals (EDCs) are compounds capable of altering and modulating the normal functioning of the endocrine system, either increasing or blocking the synthesis, release, and action of a natural hormone, or acting like a xenohormone and mimicking the physiological effects of a particular endogenous hormone (1, 2). EDCs with neurological and behavioral effects include bisphenol A, phthalates, pesticides, and organometallic compounds, such as methylmercury and organotins (OTs) (3–5). OTs are organometallic compounds with one or more bonds between a carbon atom and a tin atom. They interfere with the metabolism of the gonadal and metabolic hormones (6, 7) and present cytotoxic and genotoxic effects, notoriously trespassing the blood–brain barrier and presenting neurotoxic effects that lead to nervous system abnormalities (8–11). The outspread use of OTs in the agriculture and industry led to environmental and occupational incidents, as well as their banishment in several countries (12–15). This mini-review aims to summarize the toxicity of the main OTs in the brain and briefly presents what is known about their impact on behavior and on the central nervous system function of experimental animal models and humans.
Trimethyltin (TMT) Neurotoxicity
Trimethyltin is one of the most commonly used OTs in industry and agriculture, known for its role as a fungicide and plastic stabilizer (16). The symptoms of TMT intoxication in humans have been documented after the report of two cases, as described by Fortemps et al. (17). TMT exposure could be associated with neurological disorders, such as headaches, vigilance loss, disorientation, memory deficits, and tonic–clonic seizures. TMT also leads to developmental abnormalities in animal models, as TMT exposure causes morphological changes in the rodent hippocampus, leading to reduced expression levels of reelin (18), which is an important glycoprotein in the extracellular matrix that is involved with the migration of postmitotic neurons in the cerebral cortex and the synaptic plasticity in the developing brain (19).
Increased levels of reactive oxygen species (ROS), protein carbonyl, and malondialdehyde—biomarkers of protein and lipid peroxidation—were found in the rat hippocampus after TMT exposure (20). Those markers for oxidative stress were followed by behavioral abnormalities. The homeostasis of several antioxidant mechanisms can be altered by TMT in the hippocampus, with a decrease in the expression levels of enzymes, such as catalase, superoxide dismutase (SOD), and glutathione peroxidase (GPx), and an increase in glutathione S-transferase (GST), a detoxifying enzyme of which high levels are considered a signal of tissue damage (21, 22). Neuroinflammation is another outcome of TMT intoxication, and several biomarkers, such as activated glial cells and the expression of inflammation-related genes, appear in the brain of TMT-treated rodents. Both astrocytes and microglia release inflammatory cytokines during brain injury process, microglia being mainly responsible for the inflammatory response (23). TMT induces the activation of microglia and astrocytes and leads to the increase of the inflammatory mediators released by them. The accentuated increase of interleukin IL-1β, IL-6, and tumor necrosis factor TNF-α levels in mice hippocampus, as well as iNOS, arginase-1, IL-1β, TNF-α, and IL-6 levels in cultured astrocytes, follows TMT exposure (23). It is also reported that the TMT exposure is capable of impairing the late stages of autophagic flux in primary cultured astrocytes, leading the accumulation of protein aggregates in the cell (24). Genes involved in neuronal differentiation and astrocyte activity, inflammatory response, and apoptosis are overexpressed in the dentate gyrus region of the hippocampus, while such upregulation is not found in the cornu ammonis regions (25), adding evidence to the suggestion that TMT intoxication causes specific neuronal damage (26). We can conclude that the hippocampus is an especially TMT-vulnerable structure in the mammalian brain.
Other important studies have been proposed to explain the physiological mechanism of TMT intoxication. Neuropeptide Y and somatostatin are both upregulated in the rat hippocampus in the first 4 days after TMT exposure, correlating to the occurrence of seizures. Treatment with the anticonvulsant phenobarbital blocked the seizures and the upregulation of those hormones (27). Ogita et al. (28) presented some very interesting data that showed an influence of adrenal hormones after TMT exposure. Whereas aldosterone, an important mineralocorticoid hormone, increased TMT cytotoxicity in the mouse hippocampus, the mineralocorticoid receptor antagonist, spironolactone, protected neurons against the TMT effects. The blocking of the glucocorticoid receptor through administration of the antagonist, mifepristone, had effects similar to those caused by aldosterone (28). Similar studies linking both endogenous and exogenous glucocorticoids with the attenuation of TMT brain damage were found in the literature and suggested that the modulation of glucocorticoid receptors interferes with the oxidative stress and cytokine expression related to TMT rodent neurodegeneration models (29–31).
Tributyltin (TBT) Neurotoxicity
Tributyltin is a highly toxic OT, used initially as a plastic stabilizer and a molluscicide in agriculture, but due to its higher biocide potential, TBT was subsequently extensively used as an antifouling agent in the ships and other marine structures to prevent the adhesion of plankton and other organisms (32). Several studies have reported TBT as a reproductive toxic compound, hepatotoxic, nephrotoxic, and obesogen, and it exerts its toxicity in several groups of organisms (33–36). Neurotoxicity is also described in various experimental organisms and in cultured brain cells after TBT exposure, with oxidative stress and neuroinflammation being a common feature after TBT exposure, which leads to subsequent brain impairments. Mitra et al. observed that TBT-chloride in vivo exposure in different concentrations of 10, 20, and 30 mg/kg is capable of disrupting the blood–brain barrier and metal metabolism in the rat brain, followed by protein carbonylation and lipid peroxidation, 4 days after administration. TBT in vivo also caused astrocyte activation and overexpression of inflammatory molecules, such as IL-6, Cox-2, and NF-κB. In the same study, TBT in vitro led to neurodegeneration and apoptosis by the activation of caspase-3 and -8 (37). Evidence also suggests that TBT induces neuronal damage by suppressing the effects of GST, an important cellular antioxidant mechanism, and subsequently generating ROS (38). The endocrine disruption caused by TBT leads to reduced levels of estrogens by the competitive inhibition of aromatase (39). As the antioxidant role of estrogens in the central nervous system has been reported (40), it is possible to assume that TBT also influences the ROS generation in the brain by suppressing the circulating levels of ovarian estrogen. Ishihara et al. demonstrated that pretreatment with 17β-estradiol is capable to suppress the neuronal injury via oxidative stress in cultured hippocampus slices by the activation of the Akt signaling (41). It is interesting to note that, as we cited above, it is suggested that TBT inhibits GST activity, and the decreased activity of Akt in the cardiac tissue and subsequent oxidative stress can be caused by other GST inhibitors (42), suggesting that TBT-induced oxidative stress occurs through GST inhibition via Akt deactivation induced by low levels of estrogen in the brain, as summarized in Figure 1.
Figure 1. A possible pathway for tributyltin (TBT)-generated oxidative stress in neuronal cells. Considering the data of Ishihara and colleagues (41), supported by data of other groups, TBT leads to neuronal reactive oxygen species (ROS) production by a reduction in the estrogen levels, leading to impairments in the Akt signaling and subsequent downregulation of glutathione S-transferase (GST), an important antioxidant mechanism to protect neuronal normal function.
Rat neurons cultured with astrocytes are less vulnerable to TBT toxicity than neurons cultured purely in primary neuron cultures, indicating that astrocytes play an important role in neuroprotection against TBT toxicity effects (43). Although the hippocampus is one of the main targets of TBT toxicity, considering the deleterious effects following TBT exposure, the striatum seems to be more vulnerable than other brain regions, as ROS generation, protein carbonylation, and lipid peroxidation are more prominent in this region (44, 45). The damage in the hippocampus and the striatum caused by TBT may have cognitive implications, considering that those areas are involved in mammalian memory and learning (46, 47), but further studies in this specific subject are necessary to evaluate this possibility. Based on the presented evidence, we can infer that, like TMT toxicity that targets specific regions of the hippocampal formation, TBT also has differential effects in different brain regions and cell types.
On a cognitive point of view, estrogens are modulators of different types of memory, and their low serum levels due to aromatase inhibition or ovarian failure may be associated with behavioral abnormalities (48). In fact, the brain itself produces estrogens via brain aromatase, and this de novo synthesis in the hippocampus is fundamental to proper functioning of memory systems (49). In certain animal models, TBT can inhibit not only gonadal aromatase but also brain aromatase, as is observed in the teleost fish. In the Atlantic salmon (Salmo salar), a 7-day TBT exposure impaired neurosteroidogenesis, decreasing both the expression of the cytochrome P450 aromatase gene and activity of the expressed aromatase (50). The same gene-suppressive effects of TBT were found in male guppies (Poecilia reticulata), where two isoforms of brain aromatase were under-expressed with subsequent alterations in reproductive behavior, after TBT treatment (51). Therefore, the impact of TBT exposure on endocrine systems and its subsequent influence on the nervous system can be diverse.
Evidence suggests that the TBT obesogenic effects are not only due to influences on energy metabolism but also on food intake, as follows. Neuropeptide Y is overexpressed in female rats treated for 54 days with TBT (0.5 µg/kg), and their food intake was also increased (52). TBT exerts its toxicity in other regions of the hypothalamus, as it is shown through the disruption of the rat hypothalamus–pituitary–adrenal axis (53), although there is no current knowledge about the influence of the adrenal hormonal imbalance on brain injury caused by TBT, as reported in TMT intoxication cases. We can conclude that, besides causing obvious anomalies in the reproductive behaviors through alterations in the sexual hormone balance, TBT is also capable of interfere with behavior centers in the hypothalamus.
Neurotoxicity of Other OTs
Here, we aim to present briefly what is currently known about the neurotoxicity of dibutyltin (DBT), triethyltin (TET), and triphenyltin (TPT), as well as other OTs used in industrial activities (54, 55).
Dibutyltin is a TBT metabolite, and related compounds are used as catalysts in the fabrication of polymers, such as silicone (54). The use of DBT in the polymerization of polyvinyl chloride (PVC) is a focus of special attention, considering that PVC is largely used in water containers and tubes (56). A study with pregnant female rats exposed to DBT (10, 25 ppm, from gestational Day 6 to postnatal Day 21) demonstrated that tin can accumulate in the brain and placenta, is able to cross the placental barrier and is transferred to the offspring (57). TBT is mainly metabolized in the liver, considering the high hepatic concentrations of its metabolites, including DBT, but evidence shows that part of the TBT is also converted into DBT in the brain (58). The brain is highly susceptible to DBT toxicity, and Jenkins et al. showed that DBT causes neuronal death in concentrations 40-fold lower than TMT (59). A sub-chronic exposure to DBT (5, 10, and 20 mg/kg) increased the levels of malondialdehyde, a product from lipid peroxidation, while it decreased the activity of two major antioxidant enzymatic pathways, SOD and GPx, in the rat brain. It was also found to cause DNA damage in the cerebral cortex, probably as a result of oxidative stress. We can assume that, similar to TBT, DBT induces oxidative stress in rat cortical cells (60). The physiological mechanism underlying the DBT-induced oxidative stress is yet to be fully determined. Neurotransmitter systems are influenced by DBT intoxication, as DBT exposure decreased the levels of dopamine and serotonin in the striatum and frontal cortex, respectively, causing impairments in learning and decreased spontaneous locomotion (61). Cholinergic neurotransmission is also affected, as DBT is capable of decreasing the activity of choline acetyltransferase, the uptake of choline into synaptosomes and the myelin content of cholinergic neurons of rodents (62, 63). As the data were obtained through in vitro experiments, the behavioral outcomes of the impaired acetylcholine neurotransmission have yet to be evaluated.
Triethyltin is an environmental contaminant that comes from industrial activities, similar to TMT and TBT (55). The main neurotoxic effects of TET, including demyelination of neurons and edema, are already well-described (64–66), although the molecular mechanisms underlying such effects have yet to be discovered. TET-exposed oligodendrocyte cultures presented disruption in the mitochondrial membrane potential, disturbances in the cytoskeleton, and signs of oxidative stress and apoptosis (67), concluding that, besides causing vacuolization of the myelin sheath, TET is also cytotoxic to oligodendrocytes, the glial cells responsible for forming the myelin in the mammalian central nervous system. In addition to oligodendrocytes, astrocytes are also susceptible to TET neurotoxicity (68). The TET influence on cytoskeleton is also described in primary neuron cultures, where it interferes in actin polymerization through imbalances in calcium metabolism, leading to abnormal neurotransmitter release in different neural cell lines (69). Evidence indicates that calcium homeostasis in the brain is sensible to TET exposure, as it is also capable of inducing noradrenaline spontaneous release in rat cultured hippocampal slices by altering the functioning of calcium channels (70).
Triphenyltin was used as a biocide in antifouling marine paints and acts like an endocrine disruptor, impairing the synthesis of estrogens (55). With this in mind, it is safe to assume that TPT exposure is very similar with TBT exposure. TPT is capable of impairing the expression of brain aromatase when administered in certain periods of developments in rats (71). What is remarkable about TPT neurotoxicity is its effects as an excitotoxic compound. In an isolated cell experiment, TPT increased neuronal excitability through alterations in the voltage-dependent Na+ current of a hippocampal pyramid cell (72). Another mechanism proposed to explain TPT-induced excitotoxicity is through modifications in glutamatergic transmission by modulation of calcium homeostasis in the pre-synaptic terminal (73). It is not determined yet if calcium modulation in hippocampal neurons by TPT is similar to that observed in TET exposure.
Concluding Remarks
Although most of the OTs with commercial and environmental relevance share many similarities in their chemical properties, the physiological mechanisms underlying their neurotoxicity are vast and sometimes not fully understood. Each compound has various neuroendocrine and behavioral outcomes in different groups of vertebrates, and a close examination of their biological influence is very important to increase our current knowledge about occupational and environmental health and safety. In summary, OTs are potent neurotoxicants, leading to behavioral impairments due to brain damage in various levels caused, mainly, by oxidative stress and neuroinflammation.
Author Contributions
IF, LR, and JG: conception of the work. IF: manuscript drafting. LR, JG, and LF-L: critical revision of the work. LR, LF-L, and IF: final version approval.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The authors thank the Laboratory of Cognitive Sciences and Psychopharmacology and Laboratory of Endocrinology and Cellular Toxicology. The authors also would like to thank Radael Rezende Rodrigues, Jr. for the help in the making of the figure.
Funding
LR is funded by CNPq (proc. 456041/2014-1). IS is recipient of a graduate student fellowship from CNPq.
References
1. Colborn T, Vom Saal FS, Soto AM. Developmental effects of endocrine disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 101(5):378–84. doi:10.1289/ehp.93101378
2. Tabb M, Blumberg B. New modes of action for endocrine-disrupting chemicals. Mol Endocrinol (2006) 20(3):475–82. doi:10.1210/me.2004-0513
3. Elsworth JD, Jentsch JD, Groman SM, Roth RH, Redmond DE, Leranth C. Low circulating levels of bisphenol-A induce cognitive deficits and loss of asymmetric spine synapses in dorsolateral prefrontal cortex and hippocampus of adult male monkeys. J Comp Neurol (2015) 523(8):1248–57. doi:10.1002/cne.23735
4. Chopra V, Harley K, Lahiff M, Eskenazi B. Association between phthalates and attention deficit disorder and learning disability in U.S. children, 6–15 years. Environ Res (2014) 128:64–9. doi:10.1016/j.envres.2013.10.004
5. Leon-Olea M, Martyniuk CJ, Orlando EF, Ottinger MA, Rosenfeld C, Wolstenholme J, et al. Current concepts in neuroendocrine disruption. Gen Comp Endocrinol (2014) 203:158–73. doi:10.1016/j.ygcen.2014.02.005
6. Gibbs PE. A male genital defect in the dog-whelk, Nucella lapillus (Neogastropoda), favouring survival in a TBT-polluted area. J Mar Biol Assoc UK (1993) 73:667–78. doi:10.1017/S0025315400033208
7. Omura M, Ogata R, Kubo K, Shimasaki Y, Aou S, Oshima Y, et al. Two-generation reproductive toxicity study of tributyltin chloride in male rats. Toxicol Sci (2001) 64:197–224. doi:10.1093/toxsci/64.2.224
8. Ahmad MS, Mirza B, Hussain M, Hanif M, Ali S, Walsh MJ, et al. ATRFTIR spectroscopy detects alterations induced by organotin(IV) carboxylates in MCF-7 cells at sub-cytotoxic/-genotoxic concentrations. PMC Biophys (2008) 1:3. doi:10.1186/1757-5036-1-3
9. Varela-Ramirez A, Costanzo M, Carrasco YP, Pannell KH, Aguilera RJ. Cytotoxic effects of two organotin compounds and their mode of inflicting cell death on four mammalian cancer cells. Cell Biol Toxicol (2011) 27(3):159–68. doi:10.1007/s10565-010-9178-y
10. Bouldin TW, Goines ND, Bagnell RC, Krigman MR. Pathogenesis of trimethyltin neuronal toxicity. Ultrastructural and cytochemical observations. Am J Pathol (1981) 104(3):237–49.
11. Kruger K, Diepgrond V, Ahnefeld M, Wackerbeck C, Madeja M, Binding N, et al. Blockade of glutamatergic and GABAergic receptor channels by trimethyltin chloride. Br J Pharmacol (2005) 144(2):283–92. doi:10.1038/sj.bjp.0706083
12. Feldman RG, White RF, Eriator II. Trimethyltin encephalopathy. Arch Neurol (1993) 50:1320–4. doi:10.1001/archneur.1993.00540120035010
13. Alzieu C. Environmental impact of TBT: the French experience. Sci Total Environ (2000) 258(1–2):99–102. doi:10.1016/S0048-9697(00)00510-6
14. Evans SM. Seas at the millennium: an environmental evaluation. Mar Antifoul III Glob Issues Processes (2000) 3:247–56.
15. International Maritime Organization (IMO). International Convention on the Control of Harmful Anti-Fouling Systems on Ships. London: International Maritime Organization (IMO) (2001).
16. Boyer IJ. Toxicity of dibutyltin, tributyltin and other organotin compounds to humans and to experimental animals. Toxicology (1989) 55(3):253–98. doi:10.1016/0300-483X(89)90018-8
17. Fortemps E, Amand G, Bomboir A, Lauwerys R, Laterre EC. Trimethyltin poisoning: report of two cases. Int Arch Occup Environ Health (1978) 41:1–6. doi:10.1007/BF00377794
18. Toesca A, Geloso MC, Mongiovì AM, Furno A, Schiattarella A, Michetti F, et al. Trimethyltin modulates reelin expression and endogenous neurogenesis in the hippocampus of developing rats. Neurochem Res (2016) 41(7):1559–69. doi:10.1007/s11064-016-1869-1
19. Borrell V, Del Rio JA, Alcantara S, Derer M, Martinez A, D’Arcangelo G, et al. Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections. J Neurosci (1999) 19:1345–58.
20. Shin EJ, Suh SK, Lim YK, Jhoo WK, Hjelle OP, Ottersen OP, et al. Ascorbate attenuates trimethyltin-induced oxidative burden and neuronal degeneration in the rat hippocampus by maintaining glutathione homeostasis. Neuroscience (2005) 133:715–27. doi:10.1016/j.neuroscience.2005.02.030
21. Kaur S, Chhabra R, Nehru B. Ginkgo biloba extract attenuateshippocampal neuronal loss and cognitive dysfunction resulting fromtrimethyltin in mice. Phytomedicine (2013) 20:178–86. doi:10.1016/j.phymed.2012.10.003
22. Nagashima R, Sano S, Huong NQ, Shiba T, Ogita K. Enhanced expression of glutathione S-transferase in the hippocampus following acute treatment with trimethyltin in vivo. J Pharmacol Sci (2010) 113:267–70. doi:10.1254/jphs.09158SC
23. Kim J, Yang M, Son Y, Jang H, Kim D, Kim JC, et al. Glial activation with concurrent up-regulation of inflammatory mediators in trimethyltin-induced neurotoxicity in mice. Acta Histochem (2014) 116:1490–500. doi:10.1016/j.acthis.2014.09.003
24. Fabrizi C, Pompili E, De Vito S, Somma F, Catizone A, Ricci G, et al. Impairment of the autophagic flux in astrocytes intoxicated bytrimethyltin. Neurotoxicology (2015) 52:12–22. doi:10.1016/j.neuro.2015.10.004
25. Lefebvre-d’Hellencourt C, Harry GJ. Molecular profiles of mRNA levels in laser capture microdissected murine hippocampal regions differentially responsive to TMT-induced cell death. J Neurochem (2005) 93(1):206–20. doi:10.1111/j.1471-4159.2004.03017.x
26. Chang LW, Wenger GR, McMillan DE, Dyer RS. Species and strain comparison of acute neurotoxic effects of trimethyltin in mice and rats. Neurobehav Toxicol Teratol (1983) 5(3):337–50.
27. Ishikura N, Tsunashima K, Watanabe K, Nishimura T, Minabe Y, Kato N. Neuropeptide Y and somatostatin participate differently in the seizure-generating mechanisms following trimethyltin-induced hippocampal damage. Neurosci Res (2002) 44:237–48. doi:10.1016/S0168-0102(02)00132-3
28. Ogita K, Sugiyama C, Acosta GB, Kuramoto N, Shuto M, Yoneyama M, et al. Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethyltin-induced cytotoxicity in the mouse hippocampus. Neurosci Lett (2012) 511(2):116–9. doi:10.1016/j.neulet.2012.01.052
29. Shuto M, Higuchi K, Sugiyama C, Yoneyama M, Kuramoto N, Nagashima R, et al. Endogenous and exogenous glucocorticoids prevent trimethyltin from causing neuronal degeneration of the mouse brain in vivo: involvement of oxidative stress pathways. J Pharmacol Sci (2009) 110:424–36. doi:10.1254/jphs.09107FP
30. Liu Y, Imai H, Sadamatsu M, Tsunashima K, Kato N. Cytokines participate in neuronal death induced by trimethyltin in the rat hippocampus via type II glucocorticoid receptors. Neurosci Res (2005) 51:19–327. doi:10.1016/j.neures.2004.12.005
31. Little AR, Sriram K, O’Callaghan JP. Corticosterone regulates expression of CCL2 in the intact and chemically injured hippocampus. Neurosci Lett (2006) 399:162–6. doi:10.1016/j.neulet.2006.01.050
32. ten Hallers-Tjabbes CC, Kemp JF, Boon JP. Imposex in whelks (Buccinum undatum) from the open North Sea: relation to shipping traffic intensities. Mar Pollut Bull (1994) 28(5):311–3. doi:10.1016/0025-326X(94)90156-2
33. Gallo A, Tosti E. Adverse effect of antifouling compounds on the reproductive mechanisms of the ascidian Ciona intestinalis. Mar Drugs (2013) 11(9):3554–68. doi:10.3390/md11093554
34. Grote K, Stahlschmidt B, Talsness CE, Gericke C, Appel KE, Chahoud I. Effects of organotin compounds on pubertal male rats. Toxicology (2004) 202:145–58. doi:10.1016/j.tox.2004.05.003
35. Kanimozhi V, Palanivel K, Akbarsha MA, Kadalmani B. Tributyltin-mediated hepatic, renal and testicular tissue damage in male Syrian hamster (Mesocricetus auratus): a study on impact of oxidative stress. Springerplus (2016) 5(1):1523. doi:10.1186/s40064-016-3186-1
36. Lyssimachou A, Santos JG, Andre A, Soares J, Lima D, Guimaraes L, et al. The mammalian “obesogen” tributyltin targets hepatic triglyceride accumulation and the transcriptional regulation of lipid metabolism in the liver and brain of zebrafish. PLoS One (2015) 10(12):e0143911. doi:10.1371/journal.pone.0143911
37. Mitra S, Gera R, Siddiqui WA, Khandelwal S. Tributyltin induces oxidative damage, inflammation and apoptosis via disturbance in blood-brain barrier and metal homeostasis in cerebral cortex of rat brain: an in vivo and in vitro study. Toxicology (2013) 310:39–52. doi:10.1016/j.tox.2013.05.011
38. Ishihara Y, Kawami T, Ishida A, Yamazaki T. Tributyltin induces oxidative stress and neuronal injury by inhibiting glutathione S-transferase in rat organotypic hippocampal slice cultures. Neurochem Int (2012) 60(8):782–90. doi:10.1016/j.neuint.2012.03.004
39. Saitoh M, Yanase T, Morinaga H, Tanabe M, Mu Y, Nishi Y, et al. Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell line KGN. Biochem Biophys Res Commun (2001) 289:198–204. doi:10.1006/bbrc.2001.5952
40. Mosquera L, Colon JM, Santiago JM, Torrado AI, Melendez M, Segarra AC, et al. Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha. Brain Res (2014) 1561:11–22. doi:10.1016/j.brainres.2014.03.002
41. Ishihara Y, Fujitani N, Kawami T, Adachi C, Ishida A, Yamazaki T. Suppressive effects of 17β-estradiol on tributyltin-induced neuronal injury via Akt activation and subsequent attenuation of oxidative stress. Life Sci (2014) 99(1–2):24–30. doi:10.1016/j.lfs.2014.01.061
42. Roth E, Marczin N, Balatonyi B, Ghosh S, Kovacs V, Alotti N, et al. Effect of a glutathione S-transferase inhibitor on oxidative stress and ischemia-reperfusion-induced apoptotic signalling of cultured cardiomyocytes. Exp Clin Cardiol (2011) 16(3):92–6.
43. Oyanagi K, Tashiro T, Negishi T. Cell-type-specific and differentiation-status-dependent variations in cytotoxicity of tributyltin in cultured rat cerebral neurons and astrocytes. J Toxicol Sci (2015) 40(4):459–68. doi:10.2131/jts.40.459
44. Mitra S, Siddiqui WA, Khandelwal S. Early cellular responses against tributyltin chloride exposure in primary cultures derived from various brain regions. Environ Toxicol Pharmacol (2014) 37:1048–59. doi:10.1016/j.etap.2014.03.020
45. Mitra S, Siddiqui WA, Khandelwal S. Differential susceptibility of brain regions to tributyltin chloride toxicity. Environ Toxicol (2015) 30(12):1393–405. doi:10.1002/tox.22009
46. Warburton EC, Brown MW. Neural circuitry for rat recognition memory. Behav Brain Res (2015) 285:131–9. doi:10.1016/j.bbr.2014.09.050
47. Valle MTC, Couto-Pereira NS, Lampert C, Arcego DM, Toniazzo AP, Limberger RP, et al. Energy drinks and their component modulate attention, memory, and antioxidant defences in rats. Eur J Nutr (2017). doi:10.1007/s00394-017-1522-z
48. Tuscher JJ, Fortress AM, Kim J, Frick KM. Regulation of object recognition and object placement by ovarian sex steroid hormones. Behav Brain Res (2015) 285:140–57. doi:10.1016/j.bbr.2014.08.001
49. Tuscher JJ, Szinte JS, Starrett JR, Krentzel AA, Fortress AM, Remage-Healey L, et al. Inhibition of local estrogen synthesis in the hippocampus impairs hippocampal memory consolidation in ovariectomized female mice. Horm Behav (2016) 83:60–7. doi:10.1016/j.yhbeh.2016.05.001
50. Lyssimachou A, Jessen BM, Arukwe A. Brain cytochrome P450 aromatase gene isoforms and activity levels in Atlantic salmon after waterborne exposure to nominal environmental concentrations of the pharmaceutical ethynylestradiol and antifoulant tributyltin. Toxicol Sci (2006) 91:82–92. doi:10.1093/toxsci/kfj136
51. Tian H, Wu P, Wang W, Ru SG. Disruptions in aromatase expression in the brain, reproductive behavior, and secondary sexual characteristics in male guppies (Poecilia reticulata) induced by tributyltin. Aquat Toxicol (2015) 162:117–25. doi:10.1016/j.aquatox.2015.03.015
52. He K, Zhang J, Chen Z. Effect of tributyltin on the food intake and brain neuropeptide expression in rats. Endokrynol Pol (2014) 65(6):485–90. doi:10.5603/EP.2014.0068
53. Merlo E, Podratz PL, Sena GC, de Araújo JF, Lima LC, Alves IS, et al. The environmental pollutant tributyltin chloride disrupts the hypothalamic-pituitary-adrenal axis at different levels in female rats. Endocrinology (2016) 157(8):2978–95. doi:10.1210/en.2015-1896
54. Cervantes J, Zárraga R, Salazar-Hernández C. Organotin catalysts in organosilicon chemistry. Appl Organomet Chem (2012) 26:157–63. doi:10.1002/aoc.2832
55. Kimbrough RD. Toxicity and health effects of selected organotin compounds: a review. Environ Health Perspect (1976) 14:51–6. doi:10.1289/ehp.761451
56. Ou QR, Whang CW. Determination of butyltin and octyltin stabilizers in poly(vinyl chloride) products by headspace solid-phase microextraction and gas chromatography with flame-photometric detection. Anal Bioanal Chem (2006) 386:376. doi:10.1007/s00216-006-0657-1
57. Moser VC, McGee JK, Ehman KD. Concentration and persistence of tin in rat brain and blood following dibutyltin exposure during development. J Toxicol Environ Health A (2009) 72(1):47–52. doi:10.1080/15287390802445582
58. Omura M, Shimasaki Y, Oshima Y, Nakayama K, Kubo K, Aou S, et al. Distribution of tributyltin, dibutyltin and monobutyltin in the liver, brain and fat of rats: two-generation toxicity study of tributyltin chloride. Environ Sci (2004) 11:123–32.
59. Jenkins SM, Ehman K, Barone S Jr. Structure-activity comparison of organotin species: dibutyltin is a developmental neurotoxicant in vitro and in vivo. Brain Res Dev Brain Res (2004) 151(1–2):1–12. doi:10.1016/j.devbrainres.2004.03.015
60. Jin M, Song P, Li N, Li X, Chen J. A plastic stabilizer dibutyltin dilaurate induces subchronic neurotoxicity in rats. Neural Regen Res (2012) 7(28):2213–20. doi:10.3969/j.issn.1673-5374.2012.028.007
61. Alam MS, Husain R, Srivastava SP, Seth PK. Influence of di-butyltin dilaurate on brain. Arch Toxicol (1988) 61(5):373–7. doi:10.1007/BF00334618
62. Kobayashi H, Suzuki T, Kasashima Y, Motegi A, Sato I, Matsusaka N, et al. Effects of tri-, di- and monobutyltin on synaptic parameters of the cholinergic system in the cerebral cortex of mice. Jpn J Pharmacol (1996) 72(4):317–24. doi:10.1254/jjp.72.317
63. Eskes C, Honegger P, Jones-Lepp T, Varner K, Matthieu JM, Monnet-Tschudi F. Neurotoxicity of dibutyltin in aggregating brain cell cultures. Toxicol In Vitro (1999) 13:555–60. doi:10.1016/S0887-2333(99)00018-1
64. Smith ME. Studies on the mechanism of demyelination: myelin autolysis in normal and edematous CNS tissue. J Neurochem (1977) 28(2):341–7. doi:10.1111/j.1471-4159.1977.tb07753.x
65. Gerren RA, Groswald DE, Luttges MW. Triethyltin toxicity as a model for degenerative disorders. Pharmacol Biochem Behav (1976) 5(3):299–307. doi:10.1016/0091-3057(76)90082-4
66. Graham DI, de Jesus PV, Pleasure DE, Gonatas NK. Triethyltin sulfate-induced neuropathy in rats. Electrophysiologic, morphologic, and biochemical studies. Arch Neurol (1976) 33(1):40–8. doi:10.1001/archneur.1976.00500010042007
67. Stahnke T, Richter-Landsberg C. Triethyltin-induced stress responses and apoptotic cell death in cultured oligodendrocytes. Glia (2004) 46:334–44. doi:10.1002/glia.10341
68. Röhl C, Gülden M, Seibert H. Toxicity of organotin compounds in primary cultures of rat cortical astrocytes. Cell Biol Toxicol (2001) 17:23–32. doi:10.1023/A:1010951013855
69. Marinovich M, Viviani B, Galli CL. Actin modifications and calcium homoeostasis in neurotoxicity. The case of organotin salts. Toxicol In Vitro (1997) 11(5):499–503. doi:10.1016/S0887-2333(97)00076-3
70. Gasso S, Sanfeliu C, Sunol C, Rodriguez-Farre E, Cristofol RM. Trimethyltin and triethyltin differentially induce spontaneous noradrenaline release from rat hippocampal slices. Toxicol Appl Pharmacol (2000) 162(3):189–96. doi:10.1006/taap.1999.8845
71. Hobler C, Andrade AJ, Grande SW, Gericke C, Talsness CE, Appel KE, et al. Sex-dependent aromatase activity in rat offspring after pre-and postnatal exposure to triphenyltin chloride. Toxicology (2010) 276(3):198–205. doi:10.1016/j.tox.2010.08.003
72. Oyama Y. Modification of voltage-dependent Na+ current by triphenyltin, an environmental pollutant, in isolated mammalian brain neurons. Brain Res (1992) 583(1–2):93–9. doi:10.1016/S0006-8993(10)80012-5
Keywords: behavioral impairments, brain function, environmental contaminant, endocrine disruptor, neurotoxicity, neurodegeneration, neuroinflammation, oxidative stress
Citation: Ferraz da Silva I, Freitas-Lima LC, Graceli JB and Rodrigues LCM (2018) Organotins in Neuronal Damage, Brain Function, and Behavior: A Short Review. Front. Endocrinol. 8:366. doi: 10.3389/fendo.2017.00366
Received: 05 October 2017; Accepted: 13 December 2017;
Published: 08 January 2018
Edited by:
Takayoshi Ubuka, Monash University Malaysia, MalaysiaReviewed by:
Fumihiko Maekawa, National Institute for Environmental Studies, JapanTaisen Iguchi, National Institute for Basic Biology, Japan
Copyright: © 2018 Ferraz da Silva, Freitas-Lima, Graceli and Rodrigues. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Igor Ferraz da Silva, igor-sima@hotmail.com